RxDoctor Payments Data

Larry Smith, MD

Obstetrics & Gynecology · Richland, WANPI 1710954375

Payments from drug & device makers

What this record shows

This record is dominated by education: $4,198 of the $5,664 with a category attached, or 74.1%. Intuitive Surgical accounts for 73.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $4,624 and has fallen 98.8% since, to $54 in 2025. Among obstetrics & gynecology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,664in general payments, 2019–2025

Across 15 payments — averaging $377.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$4K
  • Coloplast$1K
  • AbbVie$112
  • Caldera Medical, Inc$45
  • Pfizer$40
  • Therapeuticsmd, Inc.$12

What the payments were for

  • Travel & lodging$1,18621%
  • Food & beverage$2354%
  • Education$4,19874%
  • Gifts$451%

General payments by program year

19
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,664 in reported general payments places this provider in the 90th percentile of 733 obstetrics & gynecology providers in Washington.

See all obstetrics & gynecology providers in Washington

Medicare billing

Part B allowed, 2024
$177,003
Medicare patients
250
Services billed
990

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron78$51,234
GemtesaVibegron35$33,350
Estradiol100$10,184
LinzessLinaclotide14$9,211
YuvafemEstradiol12$1,874
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst58$1,543
Duloxetine Hcl91$1,416
Trimethoprim11$970
Oxybutynin Chloride ErOxybutynin Chloride47$631
Clobetasol Propionate15$595
Trospium Chloride11$551
Oxycodone Hcl117$504
Allopurinol25$485
Lisinopril24$482
Fluconazole36$426

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$112$9,21114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 733 obstetrics & gynecology providers in Washington.

Other obstetrics & gynecology in Richland

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →